These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9018513)

  • 1. Pseudoephedrine is without ergogenic effects during prolonged exercise.
    Gillies H; Derman WE; Noakes TD; Smith P; Evans A; Gabriels G
    J Appl Physiol (1985); 1996 Dec; 81(6):2611-7. PubMed ID: 9018513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dose-response relationship between pseudoephedrine ingestion and exercise performance.
    Pritchard-Peschek KR; Jenkins DG; Osborne MA; Slater GJ; Taaffe DR
    J Sci Med Sport; 2014 Sep; 17(5):531-4. PubMed ID: 23988786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudoephedrine enhances performance in 1500-m runners.
    Hodges K; Hancock S; Currell K; Hamilton B; Jeukendrup AE
    Med Sci Sports Exerc; 2006 Feb; 38(2):329-33. PubMed ID: 16531903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do pseudoephedrine or phenylpropanolamine improve maximum oxygen uptake and time to exhaustion?
    Swain RA; Harsha DM; Baenziger J; Saywell RM
    Clin J Sport Med; 1997 Jul; 7(3):168-73. PubMed ID: 9262882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscular and cardiorespiratory effects of pseudoephedrine in human athletes.
    Gill ND; Shield A; Blazevich AJ; Zhou S; Weatherby RP
    Br J Clin Pharmacol; 2000 Sep; 50(3):205-13. PubMed ID: 10971304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of the urinary concentration of ephedrines in anti-doping analysis: determination of pseudoephedrine, cathine, and ephedrine after administration of over-the-counter medicaments.
    Strano-Rossi S; Leone D; de la Torre X; Botrè F
    Ther Drug Monit; 2009 Aug; 31(4):520-6. PubMed ID: 19571776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of d-pseudoephedrine and azatadine from a repeat action tablet formulation.
    Lin C; Lim J; Symchowicz S
    J Int Med Res; 1982; 10(2):122-5. PubMed ID: 7067923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pseudoephedrine on maximal cycling power and submaximal cycling efficiency.
    Hodges AN; Lynn BM; Bula JE; Donaldson MG; Dagenais MO; McKenzie DC
    Med Sci Sports Exerc; 2003 Aug; 35(8):1316-9. PubMed ID: 12900684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoephedrine and preexercise feeding: influence on performance.
    Pritchard-Peschek KR; Osborne MA; Slater GJ; Taaffe DR; Jenkins DG
    Med Sci Sports Exerc; 2013 Jun; 45(6):1152-7. PubMed ID: 23274597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary and subjective effects of a 60 mg dose of pseudoephedrine on graded treadmill exercise.
    Clemons JM; Crosby SL
    J Sports Med Phys Fitness; 1993 Dec; 33(4):405-12. PubMed ID: 8035590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products.
    Williams BO; Liao SH; Lai AA; Arnold JD; Perkins JG; Blum MR; Findlay JW
    Clin Pharm; 1984; 3(6):638-43. PubMed ID: 6509877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological, subjective and performance effects of pseudoephedrine and phenylpropanolamine during endurance running exercise.
    Chester N; Reilly T; Mottram DR
    Int J Sports Med; 2003 Jan; 24(1):3-8. PubMed ID: 12582945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative bioavailability of d-pseudoephedrine from a conventional d-pseudoephedrine sulfate tablet and from a repeat action tablet.
    Lin C; Lim J; Symchowicz S
    J Int Med Res; 1982; 10(2):126-8. PubMed ID: 7067924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the dose of combined caffeine and ephedrine preserves the ergogenic effect.
    Bell DG; Jacobs I; McLellan TM; Zamecnik J
    Aviat Space Environ Med; 2000 Apr; 71(4):415-9. PubMed ID: 10766467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold.
    Eccles R; Jawad MS; Jawad SS; Angello JT; Druce HM
    Am J Rhinol; 2005; 19(1):25-31. PubMed ID: 15794071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of urinary concentrations of pseudoephedrine and cathine after therapeutic administration of pseudoephedrine-containing medications to healthy subjects: implications for doping control analysis of these stimulants banned in sport.
    Barroso O; Goudreault D; Carbó Banús ML; Ayotte C; Mazzoni I; Boghosian T; Rabin O
    Drug Test Anal; 2012 May; 4(5):320-9. PubMed ID: 21548139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response study of the nasal decongestant and cardiovascular effects of pseudoephedrine.
    Empey DW; Young GA; Letley E; John GC; Smith P; McDonnell KA; Bagg LR; Hughes DT
    Br J Clin Pharmacol; 1980 Apr; 9(4):351-8. PubMed ID: 6155131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does pseudoephedrine increase blood pressure in patients with controlled hypertension?
    Coates ML; Rembold CM; Farr BM
    J Fam Pract; 1995 Jan; 40(1):22-6. PubMed ID: 7807033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of ephedrine after nasal application in healthy volunteers.
    Lefebvre RA; Surmont F; Bouckaert J; Moerman E
    J Pharm Pharmacol; 1992 Aug; 44(8):672-5. PubMed ID: 1359093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise.
    Bell DG; Jacobs I; Zamecnik J
    Eur J Appl Physiol Occup Physiol; 1998 Apr; 77(5):427-33. PubMed ID: 9562293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.